NCT00763802View on ClinicalTrials.gov

Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

May 31, 2011

Conditions
Diabetic Retinopathy
Trial Locations (1)

3000-548

AIBILI, Coimbra

All Listed Sponsors
collaborator

Fundação para a Ciência e a Tecnologia

OTHER

lead

Association for Innovation and Biomedical Research on Light and Image

OTHER

NCT00763802 - Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 | Biotech Hunter | Biotech Hunter